References
- Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012;7:e52893
- Committee opinion no. 529: placenta accreta. Obstet Gynecol 2012;120:207–11
- Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol 1997;177:210–14
- Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458–61
- Silver RM, Fox KA, Barton JR, et al. Center of excellence for placenta accreta. Am J Obstet Gynecol 2014. doi: 10.1016/j.ajog.2014.11.018
- Gielchinsky Y, Rojansky N, Fasouliotis SJ, Ezra Y. Placenta accreta – summary of 10 years: a survey of 310 cases. Placenta 2002;23:210–14
- Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One 2012;7:e52893
- Garmi G, Salim R. Epidemiology, #etiology, |diagnosis, and management of placenta accreta. Obstet Gynecol Int 2012;2012:873929
- Committee opinion no. 529: placenta accreta. Obstet Gynecol 2012;120:207–11. Available from: http://www.acog.org/-/media/Committee-Opinions/Committee-on-ObstetricPractice/co529.pdf?dmc=1&ts=20150328T0952536222 [last accessed 6 April 2015]
- Balayla J, Bondarenko HD. Placenta accreta and the risk of adverse maternal and neonatal outcomes. J Perinat Med 2013;41:141–9
- Eshkoli T, Weintraub AY, Sergienko R, Sheiner E. Placenta accreta: risk factors, perinatal outcomes, and consequences for subsequent births. Am J Obstet Gynecol 2013;208:219.e211–17
- Stotler B, Padmanabhan A, Devine P, et al. Transfusion requirements in obstetric patients with placenta accreta. Transfusion 2011;51:2627–33
- Hoffman MS, Karlnoski RA, Mangar D, et al. Morbidity associated with nonemergent hysterectomy for placenta accreta. Am J Obstet Gynecol 2010;202:628.e621–625
- Vinograd A, Wainstock T, Mazor M, et al. Placenta accreta is an independent risk factor for late pre-term birth and perinatal mortality. J Matern Fetal Neonatal Med 2014. [Epub ahead of print]
- Gielchinsky Y, Mankuta D, Rojansky N, et al. Perinatal outcome of pregnancies complicated by placenta accreta. Obstet Gynecol 2004;104:527–30
- Health care Cost and Utilization Project (HCUP). Introduction to the HCUP Nationwide Inpatient Sample (NIS). Rockville (MD): Agency for Healthcare Research and Quality; 2011
- Cost-to-Charge Ratio Files. 2011. Nationwide Inpatient Sample (NIS) user guide. Available from: http://www.hcup-us.ahrq.gov/db/state/costtocharge.jsp#obtain [last accessed 26 Jan 2015]
- Song X, Friedman B. Calculate cost adjustment factors by APR-DRG and CCS using selected states with detailed charges. HCUP Methods Series Report # 2008-04. Online 8 Oct 2008. Available from: http://www.hcup-us.ahrq.gov/reports/methods.jsp [last accessed 6 April 2015]
- Sun Y, Friedman B. Tools for more accurate inpatient cost estimates with HCUP databases, 2009. Errata added 25 Oct 2012. 2012. HCUP Methods Series Report # 2011–04. Online 29 Oct 2012. US. Available from: http://www.hcup-us.ahrq.gov/reports/methods/2011_04.pdf [last accessed 6 April 2015]
- NCI. Joinpoint regression program, version 4.0.1. Statistical Methodology and Applications Branch and Data Modeling Branch, Surveillance Research Program National Cancer Institute; 2013. Available from: http://surveillance.cancer.gov/joinpoint/Joinpoint_Help_4.1.1.5.pdf [last accessed 6 April 2015]
- Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000;19:335–51
- United States Department of Labor Bureau of Labor Statistics. Consumer Price Index: all urban consumers-(CPI-U); 2012. Available from: http://www.bls.gov/cpi/ [last accessed 6 April 2015]
- Using the HCUP nationwide inpatient sample to estimate trends (updated for 1988–2004). HCUP methods series Report # 2006–05 online. Available from: http://www.hcup-us.ahrq.gov/reports/methods/2006_05_NISTrendsReport_1988-2004.pdf [last accessed 25 Jan 2015]
- Read JA, Cotton DB, Miller FC. Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 1980;56:31–4
- Silver RM, Landon MB, Rouse DJ, et al. Maternal morbidity associated with multiple repeat cesarean deliveries. Obstet Gynecol 2006;107:1226–32
- Wax JR, Seiler A, Horowitz S, Ingardia CJ. Interpregnancy interval as a risk factor for placenta accreta. Conn Med 2000;64:659–61
- Morlando M, Sarno L, Napolitano R, et al. Placenta accreta: incidence and risk factors in an area with a particularly high rate of cesarean section. Acta Obstet Gynecol Scand 2013;92:457–60
- Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta 2008;29:639–45
- Kabiri D, Hants Y, Shanwetter N, et al. Outcomes of subsequent pregnancies after conservative treatment for placenta accreta. Int J Gynaecol Obstet 2014;127:206–10
- Eller AG, Bennett MA, Sharshiner M, et al. Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 2011;117:331–7